IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

NOVIELLO, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.173
AS - Asia 1.580
EU - Europa 1.195
SA - Sud America 160
AF - Africa 53
OC - Oceania 10
Totale 5.171
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.116
SG - Singapore 463
CN - Cina 460
IT - Italia 451
DE - Germania 203
HK - Hong Kong 154
BD - Bangladesh 129
BR - Brasile 123
VN - Vietnam 119
SE - Svezia 112
RU - Federazione Russa 93
IN - India 75
FR - Francia 67
GB - Regno Unito 67
NL - Olanda 57
FI - Finlandia 38
JP - Giappone 36
CA - Canada 30
KR - Corea 30
ID - Indonesia 29
ES - Italia 23
AR - Argentina 19
CI - Costa d'Avorio 18
IE - Irlanda 15
IL - Israele 12
ZA - Sudafrica 12
MX - Messico 11
AT - Austria 10
PL - Polonia 10
TR - Turchia 10
AU - Australia 9
CZ - Repubblica Ceca 9
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
IQ - Iraq 7
PK - Pakistan 6
CH - Svizzera 5
DK - Danimarca 5
JO - Giordania 5
MA - Marocco 5
PH - Filippine 5
AL - Albania 4
CO - Colombia 4
EC - Ecuador 4
EG - Egitto 4
IR - Iran 4
LU - Lussemburgo 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
BE - Belgio 3
JM - Giamaica 3
KE - Kenya 3
KZ - Kazakistan 3
MY - Malesia 3
PE - Perù 3
TH - Thailandia 3
TN - Tunisia 3
UZ - Uzbekistan 3
BG - Bulgaria 2
CR - Costa Rica 2
DZ - Algeria 2
GR - Grecia 2
LT - Lituania 2
NI - Nicaragua 2
OM - Oman 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
UY - Uruguay 2
AZ - Azerbaigian 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GI - Gibilterra 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PA - Panama 1
RE - Reunion 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
TZ - Tanzania 1
UA - Ucraina 1
Totale 5.171
Salva come PNG Salva come JPEG
Città #
Dallas 1.052
Ashburn 218
Singapore 215
Milan 173
Hong Kong 117
Frankfurt am Main 114
San Jose 103
Hefei 101
Los Angeles 58
Chandler 54
Council Bluffs 53
New York 51
Beijing 43
Hanoi 37
Bengaluru 36
Lauterbourg 36
Santa Clara 36
Chicago 33
Ho Chi Minh City 33
Hanover 26
Helsinki 26
Southend 25
Moscow 24
Buffalo 23
Jakarta 23
Seoul 22
Boardman 21
Rome 19
Abidjan 18
Atlanta 17
Nuremberg 17
Shanghai 17
Dublin 15
Guangzhou 14
Naples 14
Princeton 14
Florence 13
Munich 13
São Paulo 13
Cangzhou 12
Tokyo 12
Elk Grove Village 11
Shenzhen 11
Salt Lake City 10
Genoa 9
Amsterdam 8
Brooklyn 8
Erlangen 8
Lappeenranta 8
London 8
Montreal 8
Washington 8
Madrid 7
Seattle 7
Seravezza 7
Toronto 7
Vienna 7
Chennai 6
Da Nang 6
Des Moines 6
Tel Aviv 6
Villongo 6
Warsaw 6
Adelaide 5
Amman 5
Cambridge 5
Columbus 5
Houston 5
Orem 5
Phoenix 5
Poplar 5
Riyadh 5
Shenyang 5
Shijiazhuang 5
Tianjin 5
Wilmington 5
Ann Arbor 4
Belo Horizonte 4
Bologna 4
Boston 4
Brno 4
Brunswick 4
Dulles 4
Düsseldorf 4
Fairfield 4
Fuzhou 4
Johannesburg 4
Luxembourg 4
Mexico City 4
Novate Milanese 4
Oxford 4
Quanzhou 4
Ranchi 4
Turin 4
Turku 4
Woodbridge 4
Albiate 3
Arezzo 3
Baghdad 3
Bangkok 3
Totale 3.286
Salva come PNG Salva come JPEG
Nome #
An intestinal Th17 subset is associated with inflammation in Crohn's Disease and activated by adherent-invasive Escherichia coli (AIEC) 279
iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis 278
Nutritional and Gastroenterological Monitoring of Patients With Celiac Disease During COVID-19 Pandemic: The Emerging Role of Telemedicine and Point-of-Care Gluten Detection Tests 274
Role of serum hepatitis B core-related antigen in chronic hepatitis B infection 261
Results of the 9th Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial Intelligence in medical management and precision medicine 257
Superior predictive value of transmural over endoscopic severity for colectomy risk in ulcerative colitis: a multicenter prospective cohort study 250
Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon-? 238
Significant Differences in IBD Care and Education across Europe: Results of the Pan-European VIPER Survey 217
The Bowel-Associated Arthritis-Dermatosis Syndrome (BADAS): A Systematic Review 208
Determinants of patient trust in gastroenterology televisits: Results of machine learning analysis 197
Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study 193
AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn's disease is suppressed by rfaP and ybaT deletion 189
Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy 188
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study 184
Risankizumab, but not ustekinumab or vedolizumab, downregulates IL-23-induced mucosal pathogenic Th17 cells in patients with Crohn’s disease 160
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicentre retrospective cohort study 152
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study 149
The carbon cost of inappropriate endoscopy 137
COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association 132
Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study 109
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC) 105
Curing inflammatory bowel diseases: breaking the barriers of current therapies- emerging strategies for a definitive treatment 103
Results of the 9th Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial Intelligence in Endoscopy, Radiology and Histology in IBD Diagnostics 101
The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges 100
Letter of Reply to “Response to: COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association” 98
Trust in telemedicine from IBD outpatients during the COVID-19 pandemic 94
Results of the Ninth Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial intelligence in IBD surgery: opportunities and limitations 89
Environmental protective and risk factors in an at-risk population of subsequent Crohn's Disease 80
Revisiting fibrosis in inflammatory bowel disease: the gut thickens 76
Resolving loss of response to ustekinumab in Crohn’s disease: POWER through or switch treatment? 68
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitis 64
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class 59
Results of the 9th Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): Artificial Intelligence in IBD: Regulatory and Methodological Considerations 59
Gut virome-colonisingOrthohepadnavirusgenus is associated with ulcerative colitis pathogenesis and induces intestinal inflammationin vivo 57
Attitudes towards Vaccinations in a National Italian Cohort of Patients with Inflammatory Bowel Disease 43
Intestinal Barrier healing is superior to transmural healing to prevent disease progession in clinical remittent patients with IBD 29
Editorial: Targeting Urgency in IBD—A Historical Divide 24
AIEC-dependent pTh17 cells generation relies on distinct virulence-determinants implicated in persistence and inflammatory response of intestinal epithelial cells and macrophages 24
The long game in ulcerative colitis: mirikizumab's four-year outcomes 20
The Assessment of Multidimensional Clinical, Biological and Patient-Reported Outcomes to Evaluate the Efficacy of Add-On Lactobacillus rhamnosus GG Supplementation in Mild Ulcerative Colitis: A Randomized Pilot Trial 1
Totale 5.346
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.607
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 2 1
2021/2022189 21 8 8 13 11 7 8 13 43 16 6 35
2022/2023177 15 23 16 12 21 27 5 10 19 3 17 9
2023/2024471 7 20 11 44 105 20 69 28 29 29 41 68
2024/2025974 32 79 49 71 66 34 73 98 44 116 119 193
2025/20263.518 270 1.233 315 209 197 114 289 134 235 216 306 0
Totale 5.346